At least two kinases phosphorylate the MPM-2 epitope during Xenopus oocyte maturation by unknown
At Least Two Kinases Phosphorylate the MPM-2 
Epitope during Xenopus Oocyte Maturation 
Jian Kuang and Cheryl L. Ashorn 
Department of Clinical Investigations, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030 
Abstract.  MPM-2 antigens,  a discrete set of phos- 
phoproteins that contain similar phosphoepitopes (the 
MPM-2 epitope), are associated with various mitoti- 
cally important  structures.  The central mitotic regula- 
tor cdc2 kinase has been proposed to induce M-phase 
by phosphorylating many proteins which might include 
the MPM-2 antigens.  To clarify the relationship of 
cdc2 kinase and the MPM-2 antigens,  we developed 
an in vitro assay that enabled us to specifically detect 
the kinases that phosphorylate the MPM-2 epitope 
(ME kinases) in crude cell extracts.  Two different ME 
kinase activities were identified in unfertilized Xenopus 
eggs, neither of which was cdc2 kinase, but both ap- 
peared to be activated by the introduction of cdc2 ki- 
nase into oocytes or oocyte extract.  The two ME ki- 
nases differed in molecular size, substrate specificity, 
peptide components, and MPM-2 reactivity. The larger 
one, ME kinase-H, phosphorylated several MPM-2 
antigens,  while the smaller one, ME kinase-L, phos- 
phorylated mainly one. We purified ME kinase-L to 
near homogeneity by sequential chromatography and 
showed that it has the characteristics of the 42-kD 
microtubule-associated protein (MAP) kinase.  Our 
results support the previous finding that MAP kinase 
is activated during Xenopus oocyte maturation and 
suggest that MAP kinase may contribute to oocyte 
maturation  induction by phosphorylating one subtype 
of MPM-2 epitope. 
T 
HE entry of eukaryotic cells into mitosis is accom- 
panied by a dramatic  increase  in the level of protein 
phosphorylation (Capony et al., 1986; Karsenti et al., 
1987; Lohka et al,, 1987; Nishimoto et al., 1987). This burst 
of protein  phosphorylation  results  from the activation  of 
multiple  protein kinases  (CicireUi et al.,  1988; Halleck et 
al.,  1987) that phosphorylate a battery of proteins involved 
in both the regulatory and structural aspects of  mitosis. It has 
been shown that a key mitotic kinase is cdc2 kinase, a protein 
complex composed of p34  '~2 and a mitotic cyclin  (Nurse, 
1990). There is substantial evidence that phosphorylation by 
cdc2 kinase  of certain  structural  proteins such as lamins, 
vimentin,  caldesmon, nucleolin, and histone H1 plays an im- 
portant role in the induction  of mitosis (Nigg,  1991). How- 
ever, since many mitotic phosphoproteins  as well as kinases 
that phosphorylate them have not been identified or charac- 
terized, it is still not known how the different mitotic kinases 
orchestrate  the  multiple  phosphorylation  cascades  which 
culminate  in mitosis. 
Using an immunological  approach,  mAbs such as MPM- 
2, MPM-12, and CHO3 (Davis et al.,  1983; Ganju et al., 
1992; and Kuriyama,  1989) were produced that recognized 
individual families of mitotic phosphoproteins.  We are char- 
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acterizing  a large family of the phosphoproteins recognized 
by MPM-2 (Davis et al., 1989; Kuang et al., 1989; 1991a,b). 
MPM-2  is a  mAb raised against  mitotic HeLa cells and 
selected by preferential staining of mitotic versus interphase 
cells  using  indirect  immunofluorescence  (Davis  et  al., 
1983).  While MPM-2 staining  can be detected on certain 
structures  in  some interphase  cells (Vandre et al.,  1984, 
1986; Keryer et al.,  1987), a dramatic  increase  in MPM-2 
reactivity is observed during the G2/M transition  in all spe- 
cies tested, both plant and animal (Davis et al., 1983; Vandre 
et al., 1986; Millar et al.,  1987; Engle et al.,  1988; Kuang 
et al., 1989; Kuriyama et al., 1990). On immunoblots of mi- 
totic Hela cell extract,  MPM-2 recognizes  many polypep- 
tides  that have been shown to be synthesized  during  inter- 
phase and phosphorylated during mitotic induction (Davis et 
al.,  1983).  Phosphatase  treatment  of  MPM-2  antigens 
eliminates  MPM-2  immunoreactivity,  indicating  that  the 
mitosis-associated phosphorylation is required for MPM-2 
reactivity  (Davis et al.,  1983).  The MPM-2 antibody pro- 
tects the antigens from being dephosphorylated, suggesting 
that the phosphorylation site resides  in the epitope recog- 
nized by MPM-2 (Davis and Rao, 1987). Based on prelimi- 
nary studies,  the major phosphoamino acid in the MPM-2 
epitope seems to be threonine  (Zhao et al., 1989). One pos- 
sible explanation  for these observations is that  the mitotic 
MPM-2 antigens  contain similar  or identical  epitopes that 
are phosphorylated by a common kinase or kinases preferen- 
tially active during  the G2/M transition.  In this  study, we 
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the MPM-2 epitope and the kinases that phosphorylate them 
as MPM-2 epitope kinases (ME kinases). 
Several lines of evidence suggest that phosphorylation of 
the MPM-2 epitope during the G2/M transition plays a cru- 
cial role in the induction of mitosis. First, proteins contain- 
ing the MPM-2 epitope are localized on structures important 
in mitosis,  such as chromosomes (Hirano and Mitchison, 
1991),  spindle poles (Engle et al.,  1988; Kuriyama et al., 
1990;  Vandre et al.,  1991;  Masuda  et al.,  1992), kineto- 
chores (Vandre et al.,  1984),  the midbody (Vandre et al., 
1984), and the nuclear envelope (Harper et al.,  1990). Sec- 
ond,  chromatography of Xenopus egg  extract resulted  in 
three fractions of M-phase promoting factor (MPF) activity, 
one of which was due to cdc2 kinase and the other two ap- 
peared to be due to MPM-2 antigens, suggesting that some 
MPM-2 antigens might be mitotic regulators (Kuang et al., 
1991b).  Third, microinjection of the MPM-2 antibody into 
Xenopus oocytes or fertilized eggs or Hela cells interferes 
with  either  the  induction  or  the  completion of M-phase 
(Davis et al., 1989; Kuang et al., 1989). Finally, phosphory- 
lation of the MPM-2 epitope during M-phase induction is a 
highly conserved phenomenon, as described above. These 
observations suggest that phosphorylation and dephosphory- 
lation of the MPM-2 epitope could be one mechanism by 
which several mitotic events are coordinately regulated. 
The current model of M-phase induction is that the mitotic 
cdc2 kinase complex, which is composed of p34  cdc2 and a 
mitotic cyclin, is a central regulator that induces individual 
mitotic events directly and indirectly (Lewin,  1990; Nigg, 
1991).  It has been suggested that the mitotic MPM-2 anti- 
gens may be substrates of cdc2 kinase (Tombes et al., 1991). 
However, none of the tested substrates of cdc2 kinase, in- 
cluding histone HI, lamin, and mitotic cyclin B, are reactive 
to MPM-2 after mitotic phosphorylation, suggesting that the 
ME kinases may be different from cdc2 kinase (Davis et al., 
1983;  Ottaviano and Gerace,  1985;  Kuang et al.,  1991a). 
Determining whether cdc2 kinase is an ME kinase is essen- 
tial  to  understanding  the  role  of phosphorylation of the 
MPM-2 epitope in M-phase induction. 
The objective of  this study was to identify and characterize 
the ME kinases from unfertilized Xenopus eggs and examine 
their relationship to cdc2 kinase. Unfertilized Xenopus eggs 
are naturally arrested at the second meiotic metaphase and 
exhibit a high level of MPM-2 epitope phosphorylation (Ku- 
anget al.,  1989).  Thus, ME kinases should be present in 
their active form in unfertilized eggs.  Our strategy was to 
first develop an assay that enabled us to detect ME kinase 
activity in vitro, and then to use this assay to monitor ME 
kinase activity during chromatography of egg extract. Using 
this  strategy,  we identified two different ME kinases  and 
demonstrated that neither was cdc2 kinase but both appeared 
to be activated by it. In addition, we purified one ME kinase 
to near homogeneity and demonstrated that it was a micro- 
tubule-associated protein (MAP) kinase. 
1. Abbreviations used in this paper: MAP, microtubule-associated protein; 
MBP, myelin basic protein; ME kinases, MPM-2 epitope kinases; MPF, 
M-phase promoting factor. 
Materials and Methods 
Preparation of Oocyte and Egg Extracts 
Immature Xenopus oocytes were obtained by collagenase treatment of surgi- 
cally removed ovarian tissues (Smith et al., 1991). The dissociated oocytes 
were washed thoroughly and crushed in an equal volume of EB (Wu and 
Gerhart, 1980) or XB (Murray and Kirschner, 1989) with 10 mM DTT and 
protease inhibitors (1 mM PMSF and 0.1 mg/ml chymostatin, leupeptin, 
and pepstatin A). The homogenate was spun at 40,000 rpm at 4°C for 1 h 
in a Beckman Ti50 rotor (Beckman Instruments, Inc., Palo Alto, CA). The 
translucent layer between the lipid cap and the yolk platelets was recovered 
as oocyte extract and frozen at -70°C before use. For time course studies, 
Stage VI oocytes were defolliculated manually and incubated in modified 
Barth's solution (MBS; Gurdon,  1976) containing 1 #g/ml progesterone. 
Extracts of 50 oocytes were prepared every 30 min as described, except two 
volumes of extraction buffer were used and extracts were spun for 5 min 
in a microfuge. For microinjection experiments, manually defolliculated oo- 
cytes, maintained in MBS, were injected as described (Gurdon, 1976).  Ex- 
tracts were prepared as above. 
Unfertilized Xenopus eggs were obtained by injecting female frogs with 
700 IU of human cborionic gonadotropin (Sigma Chemical Co., St. Louis, 
MO) to induce ovulation. The eggs were dejellied in 2% cysteine in 100 
mM Tris, pH 7.8, and rinsed thoroughly in MBS (Gurdon, 1976). The dejel- 
lied eggs were crushed in an equal volume of EB with 10 mM DTT, 2 mM 
ATP-?-S and the protease inhibitors given above.  The homogenate was 
processed to obtain egg extract as described above. The extract was frozen 
at -70°C after being stored at 4°C for 1-3 d for thiophosphorylation (Kuang 
et al., 1991b). The protein concentration of the oocyte and egg extracts was 
determined to be 8-10 mg/ml by Bradford protein assay (Bio Pad Laborato- 
ries, Richmond, CA). 
In Vitro Assay for ME Kinase Activity 
To  prepare  substrate blots, 0.18-0.2  mg of immature oocyte extract in 
Laemmli sample buffer was loaded per lane for separation by 12.5% SDS- 
PAGE.  Prestained  molecular  weight  standards  (Sigma  SDS-7B)  were 
loaded in alternate lanes. The separated proteins were transblotted onto a 
nitrocellulose membrane using a buffer of 25 mM Tris,  190 mM Glycine, 
and 20% methanol before blocking for 1 h at 22°C in Blotto (50 mM Tris- 
HC1, pH 7.6, with 150 mM NaC1,  3% powdered milk, 0.05%  Tween-20, 
and 0.01% sodium azide). The substrate blots were then dried and stored 
at  -20°C before use. 
To detect phosphorylation by ME kinase, the substrate blots were cut into 
individual lanes and incubated with samples diluted with 0.25  x  EB with 
4 mM ATP, 20 mM NaF,  10 ram DTT,  and 1 #M okadaic acid. Dilution 
of the samples varied according to their estimated protein concentration. 
After gentle agitation for 1 h at 22°C, the blots were rinsed in TBS-Tween 
20 (10 mM Tris, 150 ram NaC1, and 0.05%  Tween-20) to remove residual 
extract before washing. To remove any nonspecifically bound proteins, the 
blots were washed twice in a pH 3.0 buffer (50 mM Tris, 1 M NaC1,  and 
1% NP-40), twice in the same buffer at pH 10.0, and five times in Blotto 
for 10 min each time. The blots were immunostained 2 h with the primary 
antibody (MPM-2) diluted 1:500 in TBS-Tween 20 plus 10 % calf serum be- 
fore being washed four times (10 rain each) with TBS-Tween  20. The sec- 
ondary antibody, an alkaline phosphatase conjugate (Promega, Madison, 
WI), was diluted 1:15,000 in the same buffer as the primary antibody and 
added to the blots for 1 h.  The washing procedure was repeated before 
development by 0.5 mg/ml nitro blue tetrazolium (NBT)  and 0.25 rng/ml 
5-bromo-4-chloro-3-indolyl phosphate (BCIP) (Bio pad Laboratories) in 
0.1 mM Tris-base, pH 9.5, plus 0.05 mM MgCI, 0.1 mM NaC1. The devel- 
opment was stopped by washes with deionized water. 
The purified sea star MAP kinase used in the ME kinase assay was ob- 
tained from Upstate Biotechnology Inc. (UBI) (Lake Placid, NY) and the 
purified Xenopus  MAP kinase was  a  gift  from  Drs.  Y.  Gotoh and  E. 
Nishida. 
Assay for Histone HI Kinase Activity and Myelin 
Basic Protein Phosphorylation Activity 
A 7.5-#1 aliquot of each sample was mixed with 2.5 #1 of reaction mixture. 
For the H1 kinase assay, the reaction mixture contained 0.1 mg/mi histone 
H1,  100 #M ATP, 4/an cAMP-dependent protein kinase inhibitor (Sigma 
P-3294), and 0.5 #Ci/#l  [~-32p]ATP  in EB.  For the myelin basic protein 
(MBP) kinase assay, it contained 0.5  mg/mi MBE  500 #M ATP, 4  ~tM 
The Journal  of Cell Biology,  Volume 123, 1993  860 cAMP-dependent protein kinase inhibitor, and 0.5 izCi/#l [":,-32p]ATP in 
EB.  The assay mixtures were incubated for 20  rain at 220C,  and then 
Laemmli sample buffer was added to stop the reaction. The proteins were 
separated by SDS-PAGE and autoradiographed to reveal phosphorylation 
of histone H1 or MBE To quantitate the phosphorylation, each histone H1 
or MBP band was excised from the gel and the radioactivity in it was deter- 
mined using a scintillation counter. 
Purification of  ME Kinase-L 
All chromatography was performed at 4°C in column buffer (CB) (EB with 
20 mM NaE 50/.~M ATP3,S, and 1 mM DTT). FOr Ultrogel AcA 34 (LKB, 
Houston, TX) chromatography, 1 ml of egg extract was fractionated on a 
40-ml (0.9  x  59 cm) column at a flow rate of 0.3 ml/min. 1-ml fractions 
were collected and measured for protein absorbance at 280 nM. Bio Rad 
gel filtration standards were used to calibrate the column. For Q-Sepharose 
Fast Flow chromatography, fractions 26-32 containing ME kinase-L activ- 
ity from the Ultrogel AcA 34 chromatography were pooled and applied 
directly to a 4-ml Q-Sepharose Fast Flow (Pharmacia Fine Chemicals, Pis- 
cataway, N J) column pre-equilibrated in CB. The column was then washed 
with 10 ml of CB with 50 mM NaCI and eluted with 10 ml of 0.2 M NaCI 
in CB and 10 ml of 0.4 M NaCI in CB sequentially. 1-ml fractions were col- 
lected and the peaks of flow through (QF), first eluate (QE1),  and second 
eluate (QE2) could be easily identified by their protein absorbance at 280 
urn. For Affi-Gel blue chromatography, QE1 from the Q-Sepharose chroma- 
tography was concentrated with a Centricon-30 microconcentrator (Ami- 
con, Danvers, MA) and diluted with CB to reduce the concentration of NaC1 
to less than 0.02 M. Diluted QEI from ten runs was pooled and applied to 
a 5-ml Affi-Gel blue (Bio Rad Laboratories) column pre-equilibrated in CB. 
The column was washed with 30 rnl of CB and then eluted with 30 ml of 
0.6 M  NaC1 in CB. 2-ml fractions were collected and the peaks of flow- 
through and eluate could be easily identified by their protein absorbance at 
280.  For FPLC (Waters 650 purification system; Waters, Milford MA) on 
Protein Pak 300 SW column, the eluate from Affi-G-el blue was precipitated 
sequentially with 33 and 40% saturated ammonium sulfate. The 33-40% 
ammonium sulfate precipitate, which contained most of the ME kinase-L 
activity, was resuspended in 300/~1  of CB and applied to a  15-ml Protein 
Pak 300 SW column (Waters)  at a flow rate of 0.8 ml/min while collected 
0.4-ml fractions. Bio Rad gel filtration standards were used to calibrate the 
column. 
Affinity Absorption 
MPM-2 or RDA-1 mouse ascites were produced as previously described 
(Davis et al., 1983).  RDA-I is a nucleolar antibody used as the control IgG 
for MPM-2. IgG from the ascites was bound to Afli-Prep protein A matrix 
with the binding buffer from a MAPs II kit (Bio Rad Laboratories). The 
anti-Xenopus MAP kinase (COOH terminus) antibody and the control pre- 
immune serum, kindly provided by Drs. J.  Posada and J.  Cooper, were 
bound with Affi-Prep protein A matrix. FOr immunodepletion, each sample 
was added to beads pre-equilibrated in EB and rotated at 4°C for at least 
3 h. The beads were then pelleted and the supernatants recovered. 
lmmunoblotting 
For Western blot analysis, proteins were separated by 7.5,  12.5,  or 15% 
SDS-PAGE and transblotted onto nitrocellulose. Immunostaining of the 
transblots was done as described for the in vitro ME kinase assay. The anti- 
body against rat MAP kinase NH2 terminus was obtained from Upstate 
Biotechnology Inc.  (UBI) and used at a  1:1,250  dilution.  The antibody 
against Xenopus MAP kinase COOH-terminus was used at a  1:2,000  dilu- 
tion.  The  mAb against MAP2  protein was purchased from Boehringer 
Mannheim Corp. (Indianapolis, IN) and used at a  1:15,000 dilution. The 
anti-mouse and anti-rabbit secondary AP-conjugated antibodies were ob- 
tained from Promega and used at a  1:15,000 dilution. 
Phosphorylation of  MAP2 
MAP2 protein was partially purified from rat brain tissue according to Kim 
et al. (1979).  Briefly, microtubules were isolated by two cycles of assembly 
and disassembly. The total microtubule proteins were heated at 100°C for 
10 min to precipitate tubulin and MAP1, leaving MAP2 solubilized. After 
the precipitate was removed by centrifugation, supernatant containing ap- 
proximately 30/,~g of total protein was immunoprecipitated with 30/~1 of 
or-MAP2 antibody and 100/~1 of protein A beads. For dephosphorylation, 
the immobilized MAF2 immunocomplex was incubated with 10 U of alka- 
line phosphatase (Boehringer Mannheim Corp.) in 50 mM Tris-HC1,  pH 
8.0, for 1 h at 22°C with protease inhibitors. The beads were washed thor- 
oughly with EB with 1.0 M NaC1 and 0.5% NP-40 and rinsed in plain EB. 
For phosphorylation, 20/zl of  either purified ME kinase-L or EB buffer was 
added to the beads with 5/zl of 10 izCi/lzl [3,-32P]ATP. After incubation at 
22"C for 10 min, 2 mM cold ATP was added for I h to enhance phosphory- 
lation. The reaction was stopped by addition of Laemmli sample buffer. The 
proteins were then separated by SDS-PAGE, transblotted to nitrocellulose, 
probed with MPM-2, and autoradiographed to detect 32p incorporation by 
MAP2. 
Partial Purification of  cdc2 Kinase 
Unfertilized Xenopus egg extract,  prepared as described (Kuang et al., 
1991b), was fractionated on Ultrogel AcA 34 in CB. The MPF-positive frac- 
tions, which did not include the ME kinase-H fractions, were pooled and 
subjected to Q-Sepharose chromatography (Kuang et al.,  1991b).  While 
cdc2 kinase went into the flow through, the bound proteins contained ME 
kinase-L and the two non-c,  dc2 MPFs. To further purify cdc2 kinase, the 
flow through was diluted with an equal volume of water to reduce the ionic 
strength and reapplied to a Q-Sepharose column pre-equilibrated in 0.5  x 
CB. After washing the column with 0.75  x  CB which eliminated '~90% 
of the total protein, the bound cdc2 kinase was eluted with CB plus 50 mM 
NaCI. HI kinase activity and MPF activity copurified indicating that cdc2 
kinase was responsible for the MPF activity recovered. The cdc2 kinase elu- 
ate was concentrated with Centricon 30 microconcentrator and depleted of 
MPM-2 antigens by immunoabsorption with MPM-2 affinity beads which 
immobilized neither H1 kinase nor MPF activity in the partially purified 
cdc2 kinase. On the other hand, p13  s~c/ depletion (Kuang et al.,  1991b) 
was able to cause the loss of MPF activity from the sample and its ability 
to induce the phosphorylation of  a broad spectrum of  MPM-2 antigens upon 
microinjection into Xenopus oocytes. 
Results 
Development of  an In Vitro  Assay  for ME Kinases 
To identify ME kinase, we developed an in vitro assay that 
detects its activity. The unique feature of this assay is that the 
substrates  are immobilized on nitrocellulose and MPM-2 
immunostaining is used to detect the phosphorylation. In our 
previous studies, we showed that immature Xenopus oocytes 
contain unphosphorylated MPM-2 antigens (Kuang et al., 
1989). We therefore used interphase extract prepared from 
immature Xenopus oocytes as a source of unphosphorylated 
substrates for ME kinase. To prevent potential inhibitors of 
ME kinase or activation of latent interphase ME kinase from 
interfering with the assay,  the crude interphase substrates 
were separated by SDS-PAGE and transblotted onto nitrocel- 
lulose under conditions that allowed their partial renatura- 
tion (see Materials and Methods). To perform the assay, the 
substrate blots were incubated with candidate kinase sam- 
pies in the presence of ATP and the phosphatase inhibitors, 
sodium  fluoride and  okadaic  acid.  The  blots  were  then 
rigorously  washed  under  harsh  pH  conditions  known  to 
break even antibody-antigen binding  to  eliminate  a  false 
positive result due to residual MPM-2 antigens from the ki- 
nase  sample  binding  to  the polypeptides on the blot.  To 
specifically detect phosphorylation of the MPM-2 epitope in 
the immobilized substrates, the blots were immunostained 
with the MPM-2 antibody, which recognizes only the phos- 
phorylated version of the substrates of ME kinase. 
We tested the specificity of this assay by incubating sub- 
strate blots  with  either interphase  extract from immature 
Xenopus oocytes or M-phase extract from unfertilized Xeno- 
pus eggs in the presence of [,y-32p]ATP. After incubation, 
the  blots  were  processed  for  both  autoradiography  and 
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tract did not phosphorylate any of the polypeptides on the 
blot to a significant extent (lanes I and 2). On the other hand, 
M-phase  extract catalyzed the phosphorylation of a  large 
number of polypeptides (lane 4) of which three major high- 
molecular weight bands reacted with the MPM-2 antibody 
(lane 3) under these conditions. M-phase extract contains a 
large number of MPM-2 antigens,  which could produce a 
false positive signal if any of the antigens bound to the poly- 
peptides on the substrate blots. To address this concern, two 
experiments were performed. First, 60 mM EDTA was in- 
cluded in the M-phase extract to chelate ions required by ki- 
nases for phosphorylation. The EDTA prevented the genera- 
tion of MPM-2 reactive bands on the substrate blot (data not 
shown) suggesting that de novo phosphorylation is the cause 
of the MPM-2 reactivity. Second, we included 0.1% SDS in 
the  wash  buffers  which  could  effectively break  protein- 
protein binding without eluting the majority of the trans- 
ferred polypeptides from the nitrocellulose. We found that 
the MPM-2 reactive bands  still appeared on the substrate 
blot. Together, these results indicate that 1) phosphorylation 
of the MPM-2 epitope could occur on some of the denatured 
substrates; 2) MPM-2 staining distinguished phosphoryla- 
tion of the MPM-2 epitope from other kinds of phosphoryla- 
tion; and 3) the ME kinase activity detected by this assay was 
M-phase-specific, as anticipated. It should be noted that in 
extracts  of unfertilized Xenopus eggs,  MPM-2  ordinarily 
recognizes many polypeptides ranging from 40 to 400 kD 
(Kuang et al.,  1989).  Thus, many of the substrates on the 
blots were not sufficiently renatured to be phosphorylated by 
ME kinase and/or recognized by MPM-2 in this in vitro as- 
say. It has been our experience that in immunoblot analysis, 
partial renaturation of the MPM-2 antigens from M-phase 
extract is required for MPM-2 recognition, suggesting that 
a secondary or tertiary structure is essential in the formation 
of the MPM-2 epitope. 
Identification of Two ME Kinases in Unfertilized 
Xenopus Eggs 
Using the assay described above, we analyzed the ME kinase 
activity observed in unfertilized  Xenopus eggs by chromatog- 
raphy.  Egg  extract  was  fractionated  by  gel  filtration  on 
Ultrogel AcA 34 (LKB) and individual fractions were as- 
sayed for ME kinase activity. As shown in Fig. 2 B, the assay 
detected two major peaks of ME kinase activity. One activity 
eluted slightly earlier than a 670-kD marker protein (Fig. 2 
Figure 1. In vitro assay for ME 
kinase activity. The substrate 
blots  were  prepared  as  de- 
scribed  in  Materials  and 
Methods.  They  were  incu- 
bated  with  either  interphase 
oocyte extract or M-phase egg 
extract,  diluted  1:10,  in  the 
presence  of  [-y-32P]ATP at 
22°C for 1 h. The blots were 
then  immunostained  with 
MPM-2 (lanes 1 and 3) and 
autoradiographed (lanes 2 and 
4).  The arrows indicate the 
major MPM-2 reactive bands. 
A, arrow 1) and phosphorylated mainly three major bands 
of 210,  150, and 116 kD plus several minor bands. The sec- 
ond peak of ME kinase activity eluted at 17 kD (Fig. 2 A, 
arrow 2) and phosphorylated mainly one band of 150 kD. 
The high-molecular weight ME kinase was designated ME 
kinase-H and the low-molecular weight one ME kinase-L. 
To determine whether either ME kinase contained an MPM-2 
epitope,  the peak fractions of either kinase activity were 
pooled and incubated with MPM-2 affinity beads, and the su- 
pernatants were assayed for ME kinase activity. We found 
that ME kinase-H activity could be depleted by incubation 
with  MPM-2  affinity beads,  while  ME  kinase-L activity 
could not (data not shown), demonstrating that ME kinase-H 
contains an MPM-2 epitope. The findings that ME kinase-H 
and  ME  kinase-L differ in  both  substrate  specificity and 
MPM-2 reactivity suggest that ME kinase-H is not an aggre- 
gate of ME kinase-L and that the ME kinase activity in the 
M-phase extract is due to at least two different kinases that 
phosphorylate different subsets of MPM-2 antigens in vitro. 
To determine whether cdc2 kinase exhibits ME kinase ac- 
tivity, the same fractions were also assayed for H1 kinase ac- 
tivity, a commonly used indicator of cdc2 kinase (Arion et 
al.,  1988; Draetta et al.,  1989). As shown in Fig. 2 C, two 
peaks of  ill kinase activity were observed, one eluting at 670 
kD and the other at 150 kD. The larger H1 kinase was a novel 
M-phase specific HI kinase recognized by MPM-2,  while 
the 150-kD H1 kinase was the mitotic cdc2 kinase, as shown 
in our previous studies (Kuang et al., 1991a).  Therefore, ME 
kinase-H was  completely separated  from cdc2 kinase but 
copurified with  the  larger H1  kinase while  ME  kinase-L 
overlapped but did not copurify with cdc2 kinase. To exam- 
ine the relationship between ME kinase-H and the larger HI 
kinase, fractions with ME kinase-H and the larger HI kinase 
activity were pooled and fractionated on an Atti-Gel blue 
column. While ME kinase-H activity was recovered in the 
flow-through, all the activity due to the larger H1 kinase re- 
mained bound to the column (data not shown),  indicating 
that ME kinase-H and the larger H1 kinase are different en- 
zymes. To determine whether ME kinase-L could be sepa- 
rated from cdc2 kinase, the fractions with cdc2 kinase and 
ME  kinase-L activity were pooled and  fractionated on a 
Q-Sepharose column. As shown in Fig. 3, most of the H1 ki- 
nase activity due to cdc2 kinase was in the flow-through (QF) 
which  agrees  with  our  previous  observation  that  p34  ,~2 
could only be detected in QF (Kuang et al.,  1991b).  How- 
ever, ME kinase-L was recovered in the first eluate (QE/). 
To eliminate the possibility that the inability of cdc2 kinase 
to phosphorylate the MPM-2 epitope was due to the pres- 
ence of some inhibitors in the QF fraction, purified cdc2 ki- 
nase (Solomon et al., 1990), that was highly active in phos- 
phorylating histone H1, was assayed for ME kinase activity. 
We found that the purified cdc2 kinase could not phosphory- 
late any MPM-2  epitope on the  substrate blots  (data  not 
shown) confirming that cdc2 kinase is not responsible for the 
ME kinase activity detected in this in vitro assay. 
Purification  of  ME Kinase-L 
To better characterize the ME kinases, we used sequential 
chromatography in an attempt to purify them to near homo- 
geneity. Thus far we succeeded in purifying ME kinase-L 
from M-phase egg extract with a purification strategy con- 
sisting of five steps: (a) gel filtration on Ultrogel AcA 34; (b) 
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unfertilized  egg  extract  on 
Ultrogel AcA 34.  (,4) Protein 
absorbance  of the  individual 
fractions at 280nm (OD 280 
nm).  The arrows indicate the 
protein  standards:  (1)  thyro- 
globulin  (670  kD);  and  (2) 
myoglobin (17 kD).  (B) The 
individual  fractions  were di- 
luted  1:1 and assayed for ME 
kinase activity. (C) The indi- 
vidual fractions were assayed 
for histone HI kinase activity. 
ion exchange chromatography on Q-Sepharose (Fast Flow); 
(c) affinity chromatography on Affi-Gel blue;  (d) 33-40% 
anunonium sulfate precipitation; and (e) FPLC on Protein 
Pak 300 SW (see Materials and Methods).  To optimize the 
recovery and stability of the kinase, we included adenosine- 
5'-o-(3-thiotriphosphate) (ATP'yS) in both the crude extract 
and the column running buffer. In each purification step, ME 
kinase-L activity eluted as a single peak with >50%  recov- 
ery. At the final step of purification, only one major polypep- 
tide of 42  kD was present in the fractions containing ME 
kinase-L as determined by SDS-PAGE and silver staining 
(Fig. 4). The intensity of this band correlated well with the 
kinase activity (which was quantitated by the maximum fold 
of diluted that still allowed the detection of ME kinase activ- 
ity), suggesting that the ME kinase activity is associated with 
the 42-kD protein. 
Identification of  ME Kinase-L as the 42-kD 
MAP Kinase 
Since the 42-kD MAP kinase has been shown to be active 
in M-phase Xenopus egg extract (Ferrell et al.,  1991; Gotoh 
et al.,  1991a,b; Posada et al.,  1991),  it was of interest to de- 
termine whether the purified 42-kD ME kinase-L was the 
42-kD MAP kinase. We immunoblotted the fractions from 
the final step of purification (FPLC on Protein Pak 300 SW) 
with an antibody against the highly conserved NH2-termi- 
nal domain of rat MAP kinase (Boulton et al.,  1990). In ad- 
dition, each fraction was assayed for its ability to phosphory- 
late myelin basic protein  (MBP),  a  preferred substrate  of 
MAP kinase (Gotoh et al.,  1991a).  As seen in Fig. 5,  frac- 
tions 28-31  that contained ME kinase-L activity also con- 
tained both a 42-kD immunoreactive band and high MBP- 
Figure 3.  Separation  of ME 
kinase-L  from  cdc2  kinase 
by Q-Sepharose chromatogra- 
phy.  Fractions  19-32  from 
Ultrogel AcA 34 gel filtration 
containing both ME kinase-L 
and cdc2 kinase were pooled 
and  fractionated  by Q-Seph- 
arose  chromatography.  (A) 
Protein absorbance of the in- 
dividual  fractions  at 280 nm 
(OD  280  nm)  showing the 
peaks of the flowthrough (QF), 
the 0.2 M NaC1 eluate (QE/), 
and  the  0.4  M  NaC1 eluate 
(QE2).  (B) The salt concen- 
tration of the flowthrough and 
the 0.2  M NaC1 eluate  frac- 
tions  was adjusted  to  match 
that of the 0.4 M NaC1 eluate 
fractions. The individual frac- 
tions were then diluted 1:1 and 
assayed for ME kinase activ- 
ity. (C) The individual  frac- 
tions were assayed for histone 
H1 kinase activity. 
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tein  Pak  300  SW.  (,4) In- 
dividual  fractions were mea- 
sured  for protein absorbance 
at 280 nm (OD 280 nm). The 
hatched areas indicate the ME 
kinase-L  positive  fractions. 
The arrows indicate  the pro- 
tein standards:  (1) thyroglob- 
ulin  (670  kD),  (2)  IgG (158 
kD); (3) ovalbumin  (44 kD); 
(4)  myoglobin (17  kD);  and 
(5)  vitamin  B12  (1.35 kD). 
(B)  20  /zl  of the  individual 
fractions  we're  separated  by 
20%  SDS-PAGE  and  silver 
stained.  The  maximum  fold 
dilution (MFD) is the extent to 
which the fractions could be 
diluted  and ME kinase-L ac- 
tivity still  detected.  The mi- 
nus sign (-) indicates  that no 
ME ldnase-L was detected  in 
that fraction. 
phosphorylating  activity,  indicating  copurification  of ME 
kinase-L and MAP kinase. The two polypeptides in fractions 
16-21,  which cross-reacted  with the  antibody but did  not 
have a  corresponding MBP-phosphorylating activity, could 
not be active MAP kinase and therefore were not considered 
in this study. If MAP kinase and ME kinase-L were identi- 
cal, an antibody to the 42-kD Xenopus MAP kinase should 
immunodeplete  ME  kinase-L  activity.  Using  a  polyclonal 
antibody against the COOH-terminal sequence of the 42-kD 
Xenopus MAP kinase (Posada and Cooper, 1992), we found 
Figure  5.  Copurification  of 
ME  kinase-L  activity  and 
MAP kinase. (A) 50 #1 of  frac- 
tions  16-33 from the Protein 
Pak  300  SW  gel  filtration 
were  separated  by  12.5% 
SDS-PAGE, transblotted  onto 
nitrocellulose,  and  immuno- 
stained with anti-rat  MAP ki- 
nase (NH2 terminus) antibody. 
The arrow indicates the 42-kD 
immunoreactive  band.  (B) 
The same fractious were also 
assayed for ME kinase activity 
at a 1:10  dilution and for MBP 
phosphorylating  activity,  an 
indicator of MAP kinase  ac- 
tivity.  MFD is defined  in the 
legend to Fig.  4.  The arrow 
indicates  the  phosphorylated 
MBP. 
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kinase-L  activity  by  anti- 
MAP kinase  antibody. 60/~1 
of purified ME kinase-L  was 
mixed with 60 ~1 of protein A 
beads and 60 #1 of either anti- 
Xenopus MAP kinase (COOH-terminus)  antibody or control pre- 
immune serum. The immunodepleted supernatant was then diluted 
1:10 and assayed for ME kinase activity. 
that not only did it recognize the 42-kD band in the purified 
ME kinase-L fractions (data not shown) but it immunode- 
pleted  ME  kinase-L-activity  (Fig.  6).  Finally,  like  ME 
kinase-L, purified sea star and Xenopus MAP kinases were 
both able to phosphorylate a  150-kD polypeptide in the in 
vitro assay (Fig.  7).  Taken together,  these results indicate 
that MAP kinase is responsible for ME kinase-L activity. 
To determine whether ME kinase-L could phosphorylate 
the MPM-2 epitope in immature oocyte extract which repre- 
sents a  more physiological condition,  immature oocyte ex- 
tract was incubated with or without ME kinase-L in the pres- 
ence of ATP and sodium fluoride,  a phosphatase inhibitor. 
Immunoblot analysis of the extracts indicated that addition 
of ME kinase-L could cause the appearance of a  165-kD 
MPM-2 reactive polypeptide (Fig.  8).  The result indicates 
that the phosphorylation of at least one MPM-2 antigen can 
be induced by ME kinase-L under nondenaturing conditions. 
Whether this 165-kD MPM-2 antigen is the phosphorylated 
version of the p150 observed in the ME kinase assay remains 
to be established. 
While ME kinase-H was not purified to the same extent 
as ME kinase-L, it was still of interest to determine whether 
ME kinase-H also contained the 42-kD MAP kinase as a 
subunit. Fractions from AcA 34 gel filtration of unfertilized 
egg extract, which separated the two ME kinases completely, 
were immunoblotted with the NH2-terminal anti-MAP ki- 
nase antibody and also assayed for MBP-phosphorylating ac- 
tivity. While fractions with ME kinase-L activity contained 
both the 42-kD anti-MAP kinase reactive peptide and high 
MBP-phosphorylation  activity,  the  fractions  with  ME  ki- 
nase-H activity contained neither (data not shown). There- 
fore, it is unlikely that the 42-kD MAP kinase is a peptide 
component of ME kinase-H. 
Phosphorylation of the MPM-2 Epitope on MAP2 
by ME Kinase-L 
Phosphorylation of the  MPM-2  epitope by ME  kinase-L/ 
Figure  7.  Phosphorylation  of p150 by  purified  MAP  kinases. 
Purified sea star MAP kinase (lane 1 ) and Xenopus MAP kinase 
(lane 2) were diluted 1:10  and assayed for their ability to phosphory- 
late the MPM-2 epitope in the in vitro assay. Purified ME kinase-L 
(lane 3) and M-phase egg extract (lane 4) were also diluted  1:10 
and assayed as controls for ME kinase activity. 
Figure 8. Phosphorylation of  a 
p165  native  protein  by  ME 
kinase-L.  15 td of immature 
oocyte extract was mixed  1:1 
with EB plus 50 mM NaF and 
0.5  mM ATP before  incuba- 
tion at 22°C for 1 h with or without 2/zl of purified ME kinase-L. 
These samples were then  separated  by 12.5%  SDS-PAGE along 
with a sample of ME kinase-L only (5/~1) for western blot analysis 
by MPM-2.  (Lane 1) Extract/buffer only;  (lane 2) extract/buffer 
with ME kinase-L;  and (lane 3) ME kinase-L only. 
MAP kinase raised the possibility that the MPM-2 epitope 
may be  identical  with  the  phosphorylation consensus  se- 
quence of MAP kinase. To explore this possibility, we tested 
whether MAP2 and MBP, two preferred in vitro substrates 
of MAP kinase (Gotoh et al.,  1991a), became MPM-2 reac- 
tive after phosphorylation by ME kinase-L. We found that 
MAP2 protein isolated from rat brain tissue was reactive to 
MPM-2 on immunoblots (data not shown),  indicating that 
MAP2  contained  the  phosphorylated MPM-2  epitope.  To 
test whether ME kinase-L could phosphorylate the MPM-2 
epitope on MAP2, we immunoprecipitated MAP2 onto anti- 
MAP2  affinity  beads,  dephosphorylated  it  with  alkaline 
phosphatase, and then incubated it with l~rified ME kinase-L 
or  control  buffer  in  the  presence  of /[~-32p]ATP  before 
MPM-2 immunoblotting. As shown in Fig. 9 A, after incuba- 
tion  with  ME  kinase-L,  MAP2  became  both  32p-labeled 
and reactive to MPM-2, demonstrating that the kinase phos- 
phorylates MAP2 on the MPM-2 epitope. In contrast, when 
MBP was also incubated with ME kinase-L in the presence 
of [-r-32p]ATP and immunoblotted with MPM-2,  MBP be- 
came strongly labeled with 32p but did not become reactive 
to MPM-2 (data not shown). To rule out the possibility that 
phosphorylated MBP did contain the  MPM-2  epitope but 
that  it  was  undetectable  because  of denaturation,  we  in- 
cubated phosphorylated MBP with MPM-2 or control anti- 
body affinity beads. Neither antibody immobilized any ~2p_ 
labeled MBP, confirming that phosphorylated MBP does not 
contain the MPM-2 epitope (Fig. 9 B). These findings sug- 
gest that not all substrates of MAP kinase become MPM-2 
antigens after phosphorylation.  We do not think that these 
results indicate that MAP2 and MBP contain two different 
phosphorylation sequences for MAP kinase.  Instead,  it is 
more likely that  while MAP2  and  MBP both contain  the 
MAP kinase phosphorylation consensus sequence, this con- 
sensus sequence plus the surrounding amino acid sequence 
on MAP2 comprises the MPM-2 epitope, whereas on MBP 
it does not. 
Activation of ME Kinases by cdc2 Kinase 
During Xenopus  oocyte maturation, phosphorylation of the 
MPM-2 antigens appears to coincide with the activation of 
cdc2 kinase (Kuang et al.,  1991b),  suggesting that there ex- 
ists a  regulatory relationship between them.  To determine 
whether cdc2  kinase can induce  the  activation of ME ki- 
nases, we added partially purified cdc2 kinase or buffer to 
immature oocyte extract for 30 min and then assayed the ex- 
tract for ME kinase activity. Fig.  10 A shows that while nei- 
ther cdc2 kinase alone nor immature oocyte extract exhibited 
ME kinase activity, addition of the cdc2 kinase to the oocyte 
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Dephosphorylated  MAP2,  immobilized onto anti-MAP2  affinity 
beads,  was incubated with ME kinase-L  or control buffer in the 
presence of ['y-32P]ATP  (see Materials and Methods). The MAP2 
immunocomplex was separated by 7.5% SDS-PAGE for MPM-2 
Western blot  analysis (lane  1, buffer incubated;  lane 2,  ME ki- 
nase-L  incubated).  The immunoblot  was then  autoradiographed 
(lane 3, buffer incubated; lane 4, ME kinase incubated). The arrow 
indicates the phosphorylated MAP2. (B) 15/zl of MBP-phosphory- 
lation reaction mixture (see Materials and Methods) was incubated 
with 5/~l of purified ME kinase-L. The labeled MBP was then in- 
cubated with 10 td of either MPM-2 or RDA-1 (control antibody) 
affinity beads. The proteins from the beads and the depleted super- 
natants were separated by 15 % SDS-PAGE and autoradiographed. 
The arrow indicates the phosphorylated  MBE 
extract produced an ME kinase activity comparable to that 
of  unfertilized egg extract, suggesting that both ME kinase-H 
and ME kinase-L can be activated by cdc2 kinase. If the in 
vivo activation of ME kinases is an event downstream of cdc2 
kinase, we would expect that cdc2 kinase would induce phos- 
phorylation of MPM-2 antigens upon microinjection. To test 
this possibility, we first injected partially purified cdc2 ki- 
nase into Xenopus oocytes, made extracts of the injected oo- 
cvtes,  and  assayed the  extracts  for the  appearance of the 
MPM-2 antigens. As shown in Fig.  10 B, 30 min after the 
injection,  a  broad spectrum of MPM-2  antigens  appeared 
and remained for at least 150 min. This result supports the 
possibility that cdc2 kinase can induce the activation of ME 
kinases. Finally, to determine when the ME kinases were ac- 
tivated in relation to cdc2 kinase in vivo, their activation was 
monitored during  progesterone-stimulated oocyte matura- 
tion. Oocytes were treated with progesterone and harvested 
at 30-min intervals to produce extracts which were assayed 
for both HI kinase and ME kinase activity. We found that 
cdc2 kinase and the ME kinases were activated during the 
same interval (data not shown), demonstrating a close con- 
nection between activation of cdc2 kinase and the ME ki- 
nases under physiological conditions. Taken together, these 
results suggest that during Xenopus oocyte maturation, cdc2 
kinase induces the phosphorylation of MPM-2 antigens in- 
directly via activation of the ME kinases. 
Figure 10. Activation of ME kinases by ode2 kinase. (A) 100/zl of 
immature oocyte extract was incubated for 30 rain at 22°C with 30 
#1 of either partially purified cdc2 kinase or buffer. These mixtures 
were then diluted  1:10 and assayed for ME kinase activity along 
with cdc2 kinase only and M-phase egg extract. (Lane 1 ) cdc2 ki- 
nase only; (lane 2) extract with buffer; (lane 3) extract with cdc2 
kinase;  and (lane 4) M-phase  egg extract.  (B) Partially  purified 
cdc2 kinase was microinjected into immature oocytes and every 30 
rain,  batches of 30 oocytes were collected to make extracts. The 
extracts  were  separated  by  12.5% SDS-PAGE for Western blot 
analysis by MPM-2. 
Discussion 
In this study, we used Xenopus oocyte maturation as a model 
system to  identify kinases that phosphorylate the  MPM-2 
epitope (ME kinases) during M-phase induction and exam- 
ine their relationship to the central M-phase regulator cdc2 
kinase. To achieve this, we developed an in vitro assay that 
enabled us to detect ME kinase activity in crude M-phase 
egg extract. Our findings are that (a) there exist at least two 
ME kinases in unfertilized Xenopus eggs; (b) one of the ME 
kinases,  ME kinase-L has the characteristics of the 42-kD 
MAP kinase, which in turn exhibits ME kinase-L activity; 
and (c) cdc2 kinase can activate the latent ME kinases in vivo 
in immature oocytes although it does not exhibit ME kinase 
activity in our in vitro assay. 
The  two  ME  kinases  identified  in  unfertilized Xenopus 
eggs differ in molecular size, peptide components, substrate 
specificity, and  MPM-2  reactivity. We do not exclude the 
possibility that there are more than two ME kinases in unfer- 
tilized Xenopus eggs since only a  portion of the denatured 
substrates in the in vitro assay was sufficiently renatured for 
phosphorylation of their MPM-2 epitope. Regarding the two 
ME  kinases  detected,  it  is  probable  that  the  larger  ME 
kinase-H  is  the  major  ME  kinase  responsible  for  phos- 
phorylating the majority of the MPM-2 antigens while the 
smaller ME  kinase-L is  a  minor ME  kinase which  phos- 
phorylates only a  few MPM-2  antigens.  The basis of this 
speculation is two fold. First, we showed that in the in vitro 
assay, ME kinase-H phosphorylated multiple MPM-2 anti- 
gens while ME kinase-L phosphorylated mainly one. Next, 
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can be bound by MPM-2. In our previous studies, we found 
that microinjection of MPM-2 into Xenopus oocytes before 
progesterone  stimulation  inhibits  the  phosphorylation  of 
most of the MPM-2 antigens suggesting that a major ME ki- 
nase is an MPM-2 antigen (Kuang et al.,  1989). Since ME 
kinase-H is able to both phosphorylate multiple MPM-2 an- 
tigens and react with MPM-2, it is likely to be the major ME 
kinase inhibited in the microinjection studies. We have not 
yet addressed the role of  phosphorylation of  the MPM-2 epi- 
tope on ME kinase-H in its activation. An intriguing possi- 
bility is that in Xenopus oocytes, ME kinase-H might be ini- 
tially activated via phosphorylation of its MPM-2 epitope by 
ME kinase-L, or another unidentified ME kinase, and then 
further activated by autophosphorylation. 
We have purified ME kinase-L to near homogeneity and 
shown that it is a 42-kD protein. Since Xenopus MAP kinase 
is also a 42-kD protein (Ferrell et al.,  1991; Gotoh et al., 
1991a,b; Posada et al.,  1991), we performed three indepen- 
dent experiments to address whether ME kinase-L is the 
MAP kinase previously identified in Xenopus  oocytes. First, 
we found that a major 42-kD polypeptide in the purified ME 
kinase-L fractions immunoreacted with two different MAP 
kinase antibodies.  Secondly, we showed that anti-Xenopus 
MAP kinase antibody immunodepleted ME kinase-L activ- 
ity.  Finally, we found that MAP kinase purified from Xe- 
nopus by Gotoh et al.  (1991a,b) and from sea star (UBI) 
exhibited ME kinase-L activity. Taken together, these obser- 
vations indicate that the ME kinase-L purified in this study 
is the 42-kD Xenopus MAP kinase. Two variants of Xenopus 
MAP kinase have been identified which are 98%  homolo- 
gous with each other (Gotoh et al.,  1991b;  Posada et al., 
1991).  Without knowing the amino acid  sequence of ME 
kinase-L, we cannot yet determine whether it is one of these 
variants. However, since even the 44-kD sea star MAP ki- 
nase (UBI) exhibits ME kinase activity, it is likely that both 
variants of the 42-kD Xenopus MAP kinase can phosphory- 
late the MPM-2 epitope. 
We showed that ME kinase-L not only phosphorylated the 
MPM-2 epitope on a denatured-partially renatured polypep- 
tide on the substrate blot, it also phosphorylated the MPM-2 
epitope on  the  native  protein,  MAP2.  Furthermore,  the 
purified ME kinase-L could induce phosphorylation of the 
MPM-2 epitope on at least one protein (p165) in immature 
oocyte extract in solution. We cannot eliminate the possibil- 
ity that ME kinase-L did not phosphorylate the p165 protein 
directly but activated another kinase which did. This seems 
unlikely considering that ME kinase-L can directly phos- 
phorylate the MPM-2 epitope in vitro on both the substrate 
blot and native MAP2. The most reasonable explanation is 
that ME kinase-L, which is MAP kinase, is one of the ki- 
nases that phosphorylates the MPM-2 epitope in vivo during 
Xenopus oocyte maturation. 
MAP kinase was originally identified as a  family of ki- 
nases activated during various signal transduction pathways 
(Thomas,  1992;  Pelech and Sanghera,  1992).  Recently, it 
was proposed that MAP kinase is also involved in M-phase 
induction since MAP kinase was demonstrated to be acti- 
vated during Xenopus  and sea star oocyte maturation (Ferrell 
et al., 1991; Gotoh et al., 1991a,b; Posada et al., 1991; San- 
ghera et al., 1991). It was argued that the role of MAP kinase 
during oocyte  maturation may still be in a signal transduction 
pathway and not in M-phase induction (Ferrell et al.,  1991; 
Shibuya et al., 1992). In this study, we showed that MAP ki- 
nase phosphorylates the MPM-2 epitope, which apparently 
supports the actual involvement of MAP ldnase in M-phase 
induction.  However,  although the  phosphorylation of the 
MPM-2 epitope is greatly elevated during the G2/M transi- 
tion of  various cells, it is not restricted to M-phase induction. 
For example, it has been reported that MPM-2 recognizes 
the microtubule structures of interphase neuronal cells, the 
basal bodies of flagellate cells, and certain areas of inter- 
phase nuclei in Pt K1 cells (Vandre et al.,  1986; Keryer et 
al., 1987). Since MPM-2 reactivity in those interphase cells 
is confined to a few specific structures whereas the entire 
M-phase cell reacts to MPM-2,  it is probable that the ki- 
nase(s) responsible for the interphase phosphorylation of the 
MPM-2 epitope would be different from the one(s) responsi- 
ble for phosphorylating mitotic MPM-2 antigens. Therefore, 
it is possible that MAP kinase may be an interphase ME ki- 
nase which is also expressed during oocyte maturation for 
a function not related to M-phase induction. To determine 
the role of MAP kinase during Xenopus oocyte maturation, 
we are presently purified the MPM-2 antigen phosphoryla- 
tion by MAP kinase. 
Finally, we showed that although cdc2 kinase did not ex- 
hibit ME kinase activity in our in vitro assay, it could activate 
ME kinases in immature oocyte extract and lead to the phos- 
phorylation of a broad spectrum of MPM-2 antigens when 
microinjected into immature oocytes. The simplest interpre- 
tation of these results is that in vivo, cdc2 kinase induces 
phosphorylation of MPM-2 antigens indirectly via ME ki- 
nases. One concern we have about this explanation is that we 
cannot eliminate the  possibility that in vivo, cdc2 kinase 
might be able to phosphorylate the MPM-2 epitope in some 
substrates  which  are  not  sufficiently renatured  for phos- 
phorylation in the in vitro assay. However, it is unlikely that 
cdc2 kinase is responsible for phosphorylating most MPM-2 
antigens. Statistically, if cdc2 kinase was the major ME ki- 
nase, it would be highly improbable that none of its MPM-2 
epitope-containing substrates were sufficiently renatured for 
phosphorylation while several substrates of the other ME ki- 
nases were. Therefore, even if cdc2 kinase is able to phos- 
phorylate the MPM-2 epitope in some MPM-2 antigens, its 
major role in the phosphorylation of MPM-2 antigens during 
M-phase induction is probably to activate the other ME ki- 
nases. It has been hypothesized that cdc2 kinase induces mi- 
tosis mainly by activating an array of intermediary enzymes 
(Lewin, 1990; Nigg, 1991), although few of them have been 
identified. The present study raises the possibility that the 
ME kinases act as intermediary kinases by which cdc2 ki- 
nase can induce certain events of mitosis. One issue that we 
have not addressed is the mechanism by which cdc2 kinase 
activates the ME kinases.  However, it has been shown that 
the 42-kD MAP kinase, which is ME kinase-L, is activated 
by cdc2 kinase indirectly via MAP kinase kinase (Matsuda 
et al.,  1992). Whether ME kinase-H can also be activated 
indirectly by cdc2 kinase through ME kinase-L or an uniden- 
tified kinase will be addressed in our future studies. 
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